BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Balaxi Pharmaceuticals has submitted a certificate to the stock exchange as required under SEBI's Depositories and Participants Regulations, 2018. These certificates are typically filed periodically to confirm compliance with dematerialisation (demat) requirements and the maintenance of share records. The filing is a routine regulatory obligation and does not indicate any change in business operations, financials, or strategy. No specific financial figures, dates, or additional context are disclosed in the headline.
This is a standard compliance filing with no direct impact on shareholders or the stock price. It simply reflects the company's adherence to SEBI's depository-related regulatory requirements.